http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007059211-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b22c1e0fd13e5f519424a05e86e193b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a431f1e5f5bd51f2842c97425b320542
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_be8e4ec26baa335ef3a591cbccfb5690
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-38
filingDate 2006-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d127661744ad44a0c73862ed02c9de9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbd8b9381534595e2dce65084ef53ff5
publicationDate 2007-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007059211-A2
titleOfInvention Methods of treating fibrosing diseases by induction of immune tolerance
abstract The present invention has demonstrated for the first time that orally administered type I collagen (CI) induced tolerance to CI in patients suffering from systemic sclerosis (SSc) and ameliorated clinical manifestations of the disease. Accordingly, the present invention provides methods of treating a fibrosing disease by oral administration of a tissue protein, for example, collagen, derived from the tissue undergoing fibrosis.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7939281-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8039225-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7759075-B2
priorityDate 2005-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73755215
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428545465
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137319715
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3565880
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID173839
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID5476
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3565413
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4363005
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID5476
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID588
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID33727

Total number of triples: 40.